Thomas Gruenberger

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Eric Van Cutsem, Andrés Cervantes, René Adam et al. · Annals of Oncology · 2016 · 3.3K citations · Full text

Surgical Oncology, Esmo Consensus Guidelines, Gastrointestinal Oncology +9

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius et al. · The Lancet · 2008 · 1.9K citations · Full text

Surgical Oncology, Hepatology, Gastrointestinal Oncology +9

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

Johannes Lämmer, Katarina Malagari, Thomas J. Vogl et al. · CardioVascular and Interventional Radiology · 2009 · 1.5K citations · Full text

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius et al. · The Lancet Oncology · 2013 · 1.3K citations

Perioperative Folfox4 Chemotherapy, Surgical Oncology, Hepatology +10

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein et al. · The Lancet Oncology · 2009 · 953 citations

Hepatology, Gastrointestinal Oncology, Medicine +8